Carfilnat
Brand Name: Carfilnat®
Composition: Carfilzomib for Injection (60 mg)
Presentation: Single-use vial for Intravenous use onlyManufacturer: NATCO
Product Description
Medical Info
Carfilnat® is a highly specialized oncological intervention containing Carfilzomib (60 mg/vial), manufactured under stringent quality standards by NATCO. As a potent, second-generation proteasome inhibitor, it is clinically indicated as a targeted therapeutic option for patients diagnosed with relapsed or refractory multiple myeloma. Engineered exclusively for intravenous infusion, this single-use vial works by selectively blocking targeted proteasomes, leading to the disruption of cellular processes and apoptosis within malignant plasma cells. Carfilnat® provides healthcare professionals in specialized oncology environments with a reliable and precise medical tool to effectively manage complex disease progression and improve patient outcomes.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
